Meridian Bioscience, Inc.’s (VIVO) MACD indicator has moved into bearish territory with a reading of -0.8706. The Zacks #4 Rank (“Sell”) stock decreased more than 2% to $21.11 in morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending December 2011 has decreased by 7 cents over the past month to 71 cents per share.
MERIDIAN BIOSCI (VIVO): Free Stock Analysis Report
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment